C4 Therapeutics (CCCC) Profit After Tax Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) Profit After Tax Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
C4 Therapeutics |
492.32 Mn |
256.65 Mn |
- |
4.53% |
| Date | Value |
|---|
| Mar 31, 2026 |
4.53% |
| Dec 31, 2025 |
40.73% |
| Sep 30, 2025 |
-30.41% |
| Jun 30, 2025 |
-46.87% |
| Mar 31, 2025 |
7.19% |
| Dec 31, 2024 |
0.52% |
| Sep 30, 2024 |
8.77% |
| Jun 30, 2024 |
50.68% |
| Mar 31, 2024 |
18.46% |
| Dec 31, 2023 |
6.54% |
| Sep 30, 2023 |
15.40% |
| Jun 30, 2023 |
-31.04% |
| Mar 31, 2023 |
-9.99% |
| Dec 31, 2022 |
-137.36% |
| Sep 30, 2022 |
-29.47% |
| Jun 30, 2022 |
-21.40% |
| Mar 31, 2022 |
-50.78% |
| Dec 31, 2021 |
28.12% |
| Sep 30, 2021 |
-13.04% |
| Jun 30, 2021 |
-109.21% |
